MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Overview Fund Activity
Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

164 hedge funds and large institutions have $1.21B invested in Momenta Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 82 increasing their positions, 41 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
164
Holders Change
+2
Holders Change %
+1.23%
% of All Funds
4.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
82
Reduced
41
Closed
14
Calls
$3.33M
Puts
$373K
Net Calls
+$2.96M
Net Calls Change
+$1.75M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
$84.4M
2
AC
Armistice Capital
New York
$13.9M
3
BlackRock
BlackRock
New York
$159M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
$11.8M
5
Renaissance Technologies
Renaissance Technologies
New York
$13.5M

Top Sellers

1
DCM
Discovery Capital Management
Connecticut
$20.8M
2
NI
Numeric Investors
Massachusetts
$766K
3
TCM
Tekla Capital Management
Massachusetts
$2.58M
4
FCMI
Foresite Capital Management III
California
$0
5
SAM
Senzar Asset Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
176
Prelude Capital Management
New York
– -$98K -7,369 Closed
TRCT
177
Tower Research Capital (TRC)
New York
– -$17K -1,300 Closed
4 5 6 7
8